Philip W. Rouadi
YOU?
Author Swipe
View article: Food allergy severity across the world: A World Allergy Organization international survey
Food allergy severity across the world: A World Allergy Organization international survey Open
With wide global disparities in access to diagnostic and therapeutic tools for food allergies, this condition entails a vast healthcare and economic commitment. The percentage of patients receiving a high severity diagnosis using DEFASE co…
View article: COVID-19, asthma, and biological therapies: What we need to know
COVID-19, asthma, and biological therapies: What we need to know Open
View article: WAO - ARIA consensus on chronic cough: Executive summary
WAO - ARIA consensus on chronic cough: Executive summary Open
View article: Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study Open
Background Adherence to rhinitis treatment has been insufficiently assessed. We aimed to use data from the MASK‐air mHealth app to assess adherence to oral antihistamines (OAH), intra‐nasal corticosteroids (INCS) or azelastine‐fluticasone …
View article: Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users Open
Background: The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines classify rhinitis as "intermittent" or "persistent" and "mild" or "moderate-severe". Objectives: To assess ARIA classes in a real-world study in terms of phenotyp…
View article: Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup> Open
Patient‐reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person‐centred care. This paper reviews studies performed on PROMs for assessing…
View article: Twenty-five years: The fexofenadine clinical experience
Twenty-five years: The fexofenadine clinical experience Open
Allergic rhinitis (AR) and urticaria affect a sizable portion of the population worldwide, resulting in reduced quality-of-life and productivity and increased healthcare costs. Fexofenadine (FEX) is a non-sedating second-generation H1…
View article: Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study Open
Poor AR or asthma control are associated with reduced quality of life. The estimates obtained from mobile health data may provide valuable insights for health technology assessment studies.
View article: Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study
Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study Open
View article: Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study Open
In asthma patients adherent to the MASK-air app, adherence to ICS+LABA was high. ICS+F users reported lower adherence but also a lower SABA use and a similar level of control.
View article: Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <span>ARIA‐EAACI</span> approach – ARIA‐EAACI Task Force Report Open
Biomarkers for the diagnosis, treatment and follow‐up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There ar…
View article: Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis
Rhinitis associated with asthma is distinct from rhinitis alone: The <span>ARIA‐MeDALL</span> hypothesis Open
Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly overlap in the human interactome. The concept of “one‐airway‐one‐disease,” coined over 20 years ago, is a simplistic approach of the links betwee…
View article: Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach Open
MASK‐air ® , a validated mHealth app (Medical Device regulation Class IIa) has enabled large observational implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can help to address unmet patient needs in rhi…
View article: Cutoff Values of MASK-air Patient-Reported Outcome Measures
Cutoff Values of MASK-air Patient-Reported Outcome Measures Open
View article: Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <scp>MASK</scp>‐air® longitudinal study
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <span>MASK</span>‐air® longitudinal study Open
Introduction Data from mHealth apps can provide valuable information on rhinitis control and treatment patterns. However, in MASK‐air®, these data have only been analyzed cross‐sectionally, without considering the changes of symptoms over …
View article: Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities Open
Digital health is an umbrella term which encompasses eHealth and benefits from areas such as advanced computer sciences. eHealth includes mHealth apps, which offer the potential to redesign aspects of healthcare delivery. The capacity of a…
View article: Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study Open
View article: The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis Open
View article: Digital tools in allergy and respiratory care
Digital tools in allergy and respiratory care Open
View article: Presentation of airway and general symptoms in COVID‐19 caused by dominant <scp>SARS‐CoV</scp>‐2 variants: A follow‐up on <scp>ARIA</scp> consensus
Presentation of airway and general symptoms in COVID‐19 caused by dominant <span>SARS‐CoV</span>‐2 variants: A follow‐up on <span>ARIA</span> consensus Open
Several SARS-CoV-2 variants have occurred since the beginning of the COVID-19 pandemic. Mutated variants of concerns (VOC; World Health Organization nomenclature) have a variable contamination rate and virulence. COVID-19 symptoms are poly…
View article: Comparison of rhinitis treatments using <scp>MASK</scp>‐air® data and considering the minimal important difference
Comparison of rhinitis treatments using <span>MASK</span>‐air® data and considering the minimal important difference Open
Background Different treatments exist for allergic rhinitis (AR), including pharmacotherapy and allergen immunotherapy (AIT), but they have not been compared using direct patient data (i.e., “real‐world data”). We aimed to compare AR pharm…
View article: WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19
WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19 Open
View article: Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data Open
Background Co‐medication is common among patients with allergic rhinitis (AR), but its dimension and patterns are unknown. This is particularly relevant since AR is understood differently across European countries, as reflected by rhinitis…
View article: Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model Open
Background Evidence regarding the effectiveness of allergen immunotherapy (AIT) on allergic rhinitis has been provided mostly by randomised controlled trials, with little data from real‐life studies. Objective To compare the reported contr…
View article: WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways Open
View article: WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19
WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19 Open
View article: Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air
Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air Open
View article: Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic
Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic Open
The data presented are a starting point in the process of getting feedback on all the recommendations provided by the allergy societies; it could also be the basis of new strategies to support health professionals while new COVID-19 specif…
View article: Air pollution and indoor settings
Air pollution and indoor settings Open
View article: Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19 Open
In this article, we propose that differences in COVID-19 morbidity may be associated with transient receptor potential ankyrin 1 (TRPA1) and/or transient receptor potential vanilloid 1 (TRPV1) activation as well as desensitization. TRPA1 a…